Ups and Downs | GenomeWeb

Ups and Downs

DNA sequencing has the potential to help guide cancer therapies and stave off diseases like diabetes, writes Emma Keller at the Guardian. At the same time, she says, the data it produces could be abused. "As we clamor about the loss of our privacy in the age of the internet and NSA eavesdropping, it's worth considering another aspect of public record keeping," she says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Big Three

An Eye for Flaws

Smushed In

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.